Also most of the 25 patients with a BRCA2 pathogenic/likely-pathogenic mutation had BC: 24 (96.0%) had initial BC, 6 (25.0%) of whom BBC, and 1 (4.2%) had subsequent OC. This evidence concerns the gene BRCA2 and breast cancer.